These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18495774)

  • 1. Early increases in superantigen-specific Foxp3+ regulatory T cells during mouse mammary tumor virus infection.
    Cabrera G; Burzyn D; Mundiñano J; Courreges MC; Camicia G; Lorenzo D; Costa H; Ross SR; Nepomnaschy I; Piazzon I
    J Virol; 2008 Aug; 82(15):7422-31. PubMed ID: 18495774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increases in IgA(+) B cells in Peyer's patches during milk-borne mouse mammary tumor virus infection are influenced by Toll-like receptor 4 and are completely dependent on the superantigen response.
    Cabrera G; Vercelli C; Burzyn D; Badano N; Maglioco A; Costa H; Mundiñano J; Camicia G; Nepomnaschy I; Piazzon I
    J Gen Virol; 2010 Nov; 91(Pt 11):2814-20. PubMed ID: 20685932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulatory T cell depletion increases the number of CD8 cells during mouse mammary tumor virus infection].
    Cabrera G; Mundiñano J; Camicia G; Costa H; Nepomnaschy I; Piazzon I
    Medicina (B Aires); 2011; 71(3):243-6. PubMed ID: 21745773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity.
    Papiernik M; do Carmo Leite-de-MoraesM ; Pontoux C; Joret AM; Rocha B; Penit C; Dy M
    J Immunol; 1997 May; 158(10):4642-53. PubMed ID: 9144476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen.
    Baribaud F; Maillard I; Vacheron S; Brocker T; Diggelmann H; Acha-Orbea H
    J Virol; 1999 Oct; 73(10):8403-10. PubMed ID: 10482591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
    Wrona TJ; Lozano M; Binhazim AA; Dudley JP
    J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal infection with a milk-borne virus is independent of beta7 integrin- and L-selectin-expressing lymphocytes.
    Czarneski J; Berguer P; Bekinschtein P; Kim DC; Hakimpour P; Wagner N; Nepomnaschy I; Piazzon I; Ross SR
    Eur J Immunol; 2002 Apr; 32(4):945-56. PubMed ID: 11920560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV; Dudley JP; Ross SR
    J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly sensitive in vitro infection assay to explore early stages of mouse mammary tumor virus infection.
    Vacheron S; Renno T; Acha-Orbea H
    J Virol; 1997 Oct; 71(10):7289-94. PubMed ID: 9311804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class II hierarchy of superantigen presentation predicts efficiency of infection with mouse mammary tumor virus.
    Held W; Waanders GA; MacDonald HR; Acha-Orbea H
    Int Immunol; 1994 Sep; 6(9):1403-7. PubMed ID: 7819149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial stages of mammary tumor virus infection are superantigen independent.
    Pobezinskaya Y; Chervonsky AV; Golovkina TV
    J Immunol; 2004 May; 172(9):5582-7. PubMed ID: 15100301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss.
    Barnett A; Mustafa F; Wrona TJ; Lozano M; Dudley JP
    J Virol; 1999 Aug; 73(8):6634-45. PubMed ID: 10400761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
    Beutner U; McLellan B; Kraus E; Huber BT
    Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to mouse mammary tumor virus in mice lacking the alpha/beta interferon or the gamma interferon receptor.
    Maillard I; Launois P; Xenarios I; Louis JA; Acha-Orbea H; Diggelmann H
    J Virol; 1998 Apr; 72(4):2638-46. PubMed ID: 9525580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with a mouse mammary tumour virus envelope protein epitope protects against tumour formation without inhibition of the virus infection.
    Astori M; Karapetian O
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1935-9. PubMed ID: 9266991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two infectious mouse mammary tumour viruses: superantigenicity and tumorigenicity.
    Buggiano V; Goldman A; Nepomnaschy I; Bekinschtein P; Berguer P; Lombardi G; Deroche A; Francisco MV; Piazzon I
    Scand J Immunol; 1999 Mar; 49(3):269-77. PubMed ID: 10102644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nasal-associated lymphoid tissue of adult mice acts as an entry site for the mouse mammary tumor retrovirus.
    Velin D; Fotopoulos G; Luthi F; Kraehenbuhl JP
    J Exp Med; 1997 May; 185(10):1871-6. PubMed ID: 9151713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
    J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.
    Luther SA; Maillard I; Luthi F; Scarpellino L; Diggelmann H; Acha-Orbea H
    J Immunol; 1997 Sep; 159(6):2807-14. PubMed ID: 9300703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential infection of immature dendritic cells and B cells by mouse mammary tumor virus.
    Vacheron S; Luther SA; Acha-Orbea H
    J Immunol; 2002 Apr; 168(7):3470-6. PubMed ID: 11907107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.